NASDAQ : AXSM

Axsome Therapeutics, Inc. — Stock Grades

$238.5287 USD

$0.16 (0.07%)

Volume
124.35K
Average Volume
942.42K
Market Capitalization
$12.27B
P/E Ratio
-63.95
Dividend Yield
0.00%
Price Target
$260.00
Year High
$260.19
Year Low
$96.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.39
AXSM Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-15 HC Wainwright & Co. Buy Buy Maintain
2026-07-08 HC Wainwright & Co. Buy Buy Maintain
2026-07-07 RBC Capital Outperform Outperform Maintain
2026-06-17 TD Cowen Buy Buy Maintain
2026-05-05 Mizuho Outperform Outperform Maintain
2026-05-05 Guggenheim Buy Buy Maintain
2026-05-05 Needham Buy Buy Maintain
2026-05-05 RBC Capital Outperform Outperform Maintain
2026-05-05 HC Wainwright & Co. Buy Buy Maintain
2026-05-05 Baird Outperform Outperform Maintain
2026-05-05 Morgan Stanley Equal Weight Equal Weight Maintain
2026-05-05 Wells Fargo Overweight Overweight Maintain
2026-05-04 Jefferies Buy Buy Maintain
2026-05-04 HC Wainwright & Co. Buy Buy Maintain
2026-05-01 Needham Buy Buy Maintain
2026-04-10 UBS Buy Buy Maintain
2026-03-25 Guggenheim Buy Buy Maintain
2026-02-24 RBC Capital Outperform Outperform Maintain
2026-02-24 Wells Fargo Overweight Overweight Maintain
2026-02-24 UBS Buy Buy Maintain
2026-02-24 Guggenheim Buy Buy Maintain
2026-02-23 Needham Buy Buy Maintain
2026-02-03 Jefferies Buy Buy Maintain
2026-01-28 Leerink Partners Outperform Outperform Maintain
2026-01-21 RBC Capital Outperform Outperform Maintain
2026-01-20 HC Wainwright & Co. Buy Buy Maintain
2026-01-16 Piper Sandler Overweight Overweight Maintain
2026-01-13 Wells Fargo Overweight Overweight Maintain
2026-01-08 Morgan Stanley Overweight Equal Weight Downgrade
2026-01-06 UBS Buy Buy Maintain
2026-01-05 HC Wainwright & Co. Buy Buy Maintain